Vincenzo Micale

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Aortic Dissection

Fluorescent Probe

Prefrontal Cortex

Top Venues

CNS neuroscience & therapeutics

Pharmacological reports : PR

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Katerina Horska, Silje Skrede, Jan Kucera, Gabriela Kuzminova, Pavel Suchy, Vincenzo Micale, Jana Ruda-Kucerova
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model. CNS neuroscience & therapeutics 30 (2) (2024)
Katerina Horska, Silje Skrede, Jan Kucera, Gabriela Kuzminova, Pavel Suchy, Vincenzo Micale, Jana Ruda-Kucerova
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model. CNS neuroscience & therapeutics 30 (2) (2024)
Francesca Frescura, Tibor Stark, Maria C Tomasini, Serena Di Martino, Jana Ruda-Kucerova, Filippo Drago, Luca Ferraro, Vincenzo Micale, Sarah Beggiato
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats. Pharmacological reports : PR 76 (4) (2024)
Katerina Horska, Silje Skrede, Jan Kucera, Gabriela Kuzminova, Pavel Suchy, Vincenzo Micale, Jana Ruda-Kucerova
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model. CNS neuroscience & therapeutics 30 (2) (2024)
Francesca Frescura, Tibor Stark, Maria C Tomasini, Serena Di Martino, Jana Ruda-Kucerova, Filippo Drago, Luca Ferraro, Vincenzo Micale, Sarah Beggiato
Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats. Pharmacological reports : PR (2024)
Federica Conti, Serena Di Martino, Filippo Drago, Claudio Bucolo, Vincenzo Micale, Vincenzo Montano, Gabriele Siciliano, Michelangelo Mancuso, Piervito Lopriore
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? International journal of molecular sciences 24 (23) (2023)